These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 22278155)

  • 1. Prognostic significance of transforming growth factor beta (TGF-β) signaling axis molecules and E-cadherin in colorectal cancer.
    Lampropoulos P; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
    Tumour Biol; 2012 Aug; 33(4):1005-14. PubMed ID: 22278155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.
    Javle M; Li Y; Tan D; Dong X; Chang P; Kar S; Li D
    PLoS One; 2014; 9(1):e85942. PubMed ID: 24465802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
    Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimetastatic role of Smad4 signaling in colorectal cancer.
    Zhang B; Halder SK; Kashikar ND; Cho YJ; Datta A; Gorden DL; Datta PK
    Gastroenterology; 2010 Mar; 138(3):969-80.e1-3. PubMed ID: 19909744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction of miR-3613-3p as a regulator of transforming growth factor-β (TGF-β) signaling pathway in colorectal cancer.
    Jafarian M; Hasannia T; Badameh P; Behmanesh M; Soltani BM
    Mol Biol Rep; 2024 Jun; 51(1):728. PubMed ID: 38861185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smad7 induces hepatic metastasis in colorectal cancer.
    Halder SK; Rachakonda G; Deane NG; Datta PK
    Br J Cancer; 2008 Sep; 99(6):957-65. PubMed ID: 18781153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of transforming growth factor beta-1 in cancer tissue predicts a poor prognosis for patients with stage III rectal cancers.
    Chun HK; Jung KU; Choi YL; Hong HK; Kim SH; Yun SH; Kim HC; Lee WY; Cho YB
    Oncology; 2014; 86(3):159-69. PubMed ID: 24643220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of TGF-beta1, its receptor TGFbetaRII, and Smad proteins in the progression of colorectal cancer.
    Gulubova M; Manolova I; Ananiev J; Julianov A; Yovchev Y; Peeva K
    Int J Colorectal Dis; 2010 May; 25(5):591-9. PubMed ID: 20165854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary Study of the Role F-Box Protein 32 (FBXO32) in Colorectal Neoplasms Through the Transforming Growth Factor beta (TGF-β)/Smad4 Signalling Pathway.
    Yuan X; Zhang Z; Jiang K; Wang X; Li Y
    Med Sci Monit; 2018 Feb; 24():1080-1088. PubMed ID: 29465067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Smad signaling in human colorectal cancer is associated with advanced disease and poor prognosis.
    Xie W; Rimm DL; Lin Y; Shih WJ; Reiss M
    Cancer J; 2003; 9(4):302-12. PubMed ID: 12967141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the impact of SMAD2 and SMAD4 downregulation in colorectal cancer and their correlation with immune markers, prognosis, and drug resistance and sensitivity.
    Amani MS; Peymani M
    Mol Biol Rep; 2024 Jul; 51(1):831. PubMed ID: 39037563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics.
    Figueroa JD; Flanders KC; Garcia-Closas M; Anderson WF; Yang XR; Matsuno RK; Duggan MA; Pfeiffer RM; Ooshima A; Cornelison R; Gierach GL; Brinton LA; Lissowska J; Peplonska B; Wakefield LM; Sherman ME
    Breast Cancer Res Treat; 2010 Jun; 121(3):727-35. PubMed ID: 19937272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of VEGF-C and Smad4 in the lymphangiogenesis, lymphatic metastasis, and prognosis in colon cancer.
    Li X; Liu B; Xiao J; Yuan Y; Ma J; Zhang Y
    J Gastrointest Surg; 2011 Nov; 15(11):2001-10. PubMed ID: 21786062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
    Fanayan S; Firth SM; Baxter RC
    J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling.
    Torbenson M; Marinopoulos S; Dang DT; Choti M; Ashfaq R; Maitra A; Boitnott J; Wilentz RE
    Hum Pathol; 2002 Sep; 33(9):871-6. PubMed ID: 12378510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of the Transforming Growth Factor β/Smad Pathway, Body Mass Index, and Physical Activity With Breast Cancer Outcomes: Results From the Shanghai Breast Cancer Study.
    Su Y; Cai H; Zheng Y; Qiu Q; Lu W; Shu XO; Cai Q
    Am J Epidemiol; 2016 Oct; 184(7):501-509. PubMed ID: 27651382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-β promotes aggressiveness and invasion of clear cell renal cell carcinoma.
    Sitaram RT; Mallikarjuna P; Landström M; Ljungberg B
    Oncotarget; 2016 Jun; 7(24):35917-35931. PubMed ID: 27166254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.
    Busch S; Acar A; Magnusson Y; Gregersson P; Rydén L; Landberg G
    Oncogene; 2015 Jan; 34(1):27-38. PubMed ID: 24336330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.